Stock News

Teachers Retirement System Of The State Of Kentucky Has Boosted By $2.62 Million Its Boeing Co (BA) Holding; Shorts at Tracon Pharmaceuticals (TCON) Lowered By 11.05%

The Boeing Company (NYSE:BA) Logo

Tracon Pharmaceuticals Inc (NASDAQ:TCON) had a decrease of 11.05% in short interest. TCON’s SI was 170,700 shares in April as released by FINRA. Its down 11.05% from 191,900 shares previously. With 178,300 avg volume, 1 days are for Tracon Pharmaceuticals Inc (NASDAQ:TCON)’s short sellers to cover TCON’s short positions. The SI to Tracon Pharmaceuticals Inc’s float is 1.72%. The stock decreased 7.27% or $0.2 during the last trading session, reaching $2.55. About 232,069 shares traded or 19.33% up from the average. TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) has declined 46.43% since April 25, 2017 and is downtrending. It has underperformed by 57.98% the S&P500.

Teachers Retirement System Of The State Of Kentucky increased Boeing Co (BA) stake by 5.97% reported in 2017Q4 SEC filing. Teachers Retirement System Of The State Of Kentucky acquired 8,900 shares as Boeing Co (BA)’s stock rose 8.82%. The Teachers Retirement System Of The State Of Kentucky holds 158,085 shares with $46.62M value, up from 149,185 last quarter. Boeing Co now has $201.34 billion valuation. The stock increased 4.19% or $13.8 during the last trading session, reaching $342.86. About 10.96M shares traded or 86.40% up from the average. The Boeing Company (NYSE:BA) has risen 82.35% since April 25, 2017 and is uptrending. It has outperformed by 70.80% the S&P500.

Among 4 analysts covering Tracon Pharmaceuticals Inc (NASDAQ:TCON), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Tracon Pharmaceuticals Inc had 4 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was initiated by Roth Capital on Wednesday, July 29 with “Buy”. TH Capital initiated the shares of TCON in report on Wednesday, July 29 with “Buy” rating. The rating was initiated by Jefferies on Wednesday, December 21 with “Buy”. As per Friday, September 4, the company rating was upgraded by Zacks.

TRACON Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for cancer, wet age-related macular degeneration , and fibrotic diseases. The company has market cap of $75.69 million. The Company’s lead product candidate is TRC105, an endoglin antibody, which is in Phase III clinical trials for angiosarcoma; randomized Phase II clinical trials for renal cell carcinoma; Phase II clinical trials for soft tissue sarcoma; Phase II clinical trials for gestational trophoblastic neoplasia; Phase I/II clinical trials for hepatocellular carcinoma; Phase I clinical trial for lung cancer; Phase I/II clinical trials for breast cancer; and Phase I/II clinical trials for wet AMD. It currently has negative earnings. The companyÂ’s other product candidates comprise TRC102, a small molecule that is in Phase II clinical trials for mesothelioma, Phase II clinical trials for glioblastoma, Phase I clinical trial for solid tumors and lymphomas, as well as Phase I clinical trial for lung cancer; and TRC253, a small molecule high affinity competitive inhibitor of wild type androgen receptor (AR) and multiple AR mutant receptors that is in Phase I/II clinical trials for the treatment prostate cancer.

Teachers Retirement System Of The State Of Kentucky decreased Ionis Pharmaceuticals Inc stake by 6,374 shares to 104,288 valued at $5.25M in 2017Q4. It also reduced Total Sa (NYSE:TOT) stake by 25,200 shares and now owns 833,400 shares. Wal (NYSE:WMT) was reduced too.

Among 25 analysts covering Boeing (NYSE:BA), 18 have Buy rating, 1 Sell and 6 Hold. Therefore 72% are positive. Boeing had 111 analyst reports since August 26, 2015 according to SRatingsIntel. Cowen & Co maintained it with “Buy” rating and $320.0 target in Friday, December 1 report. The rating was maintained by RBC Capital Markets with “Hold” on Friday, October 6. The rating was maintained by UBS with “Neutral” on Friday, August 4. The rating was maintained by Buckingham Research on Thursday, February 8 with “Neutral”. RBC Capital Markets maintained The Boeing Company (NYSE:BA) rating on Friday, February 12. RBC Capital Markets has “Sector Perform” rating and $128 target. The stock has “Buy” rating by Jefferies on Tuesday, May 30. As per Wednesday, January 17, the company rating was maintained by Seaport Global. The rating was maintained by Robert W. Baird on Thursday, July 27 with “Buy”. The stock of The Boeing Company (NYSE:BA) has “Outperform” rating given on Thursday, October 6 by Robert W. Baird. The rating was maintained by Cowen & Co on Thursday, September 17 with “Outperform”.

Investors sentiment decreased to 0.79 in Q4 2017. Its down 0.02, from 0.81 in 2017Q3. It dived, as 65 investors sold BA shares while 614 reduced holdings. 148 funds opened positions while 391 raised stakes. 373.50 million shares or 9.30% less from 411.79 million shares in 2017Q3 were reported. Moreover, Etrade Ltd Liability Co has 0.1% invested in The Boeing Company (NYSE:BA). National Bank Hapoalim Bm stated it has 0.05% in The Boeing Company (NYSE:BA). Clarivest Asset Mgmt Lc stated it has 288,636 shares or 1.46% of all its holdings. Clear Harbor Asset Mngmt Ltd Limited Liability Company has invested 0.06% in The Boeing Company (NYSE:BA). Synovus Fincl, a Georgia-based fund reported 24,633 shares. Verition Fund Mngmt Ltd Co reported 0.03% stake. Convergence Invest Lc has invested 1.77% of its portfolio in The Boeing Company (NYSE:BA). State Street Corporation accumulated 28.00M shares or 0.66% of the stock. White Pine Cap Ltd holds 0.29% of its portfolio in The Boeing Company (NYSE:BA) for 2,705 shares. Strs Ohio has 545,519 shares. Rockefeller Financial holds 1,697 shares or 0.01% of its portfolio. 4,916 were accumulated by Highstreet Asset Mngmt. Paragon Management Limited reported 2,861 shares. 233,174 were accumulated by Fred Alger Mgmt. King Luther Management has 16,660 shares.

Since February 8, 2018, it had 0 insider purchases, and 1 sale for $12.17 million activity. $12.17 million worth of The Boeing Company (NYSE:BA) was sold by Smith Gregory D on Thursday, February 8.

The Boeing Company (NYSE:BA) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *